[Form 4] InspireMD, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Director Gary S. Roubin received 48,000 restricted shares of InspireMD common stock on 10/07/2025. The shares were issued at $0 and will vest on 10/07/2026 subject to continued service, increasing his total beneficial ownership to 656,425 shares. The grant is recorded as restricted stock and the transaction was reported on a Form 4 filed by a single reporting person.

Positive

• 48,000 restricted shares granted to a director aligns incentives with shareholders
• One‑year vesting links award to continued service through 10/07/2026

Negative

• Potential dilution of 48,000 shares when the restricted stock vests

Insights

Corporate Governance Expert

Director received time‑based restricted stock to align incentives with shareholders.

The grant of 48,000 restricted shares vests in one year on 10/07/2026, tying compensation to continued board service. Time‑based restricted stock is a routine mechanism to retain directors and align their interests with long‑term shareholder value.

This award raises the director's beneficial ownership to 656,425 shares and will have a dilutive effect equal to the 48,000 shares if issued; the main dependency is the director's continued service through the vesting date and any company policies that might accelerate vesting. Monitor outstanding share count and future equity grants over the next 12 months for cumulative dilution trends.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROUBIN GARY S

(Last) (First) (Middle)

C/O INSPIREMD, INC.

6303 WATERFORD DISTRICT DRIVE, SUITE 215

(Street)

MIAMI FL 33126

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
InspireMD, Inc. [ NSPR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/07/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/07/2025		A		48,000(1)	A	$0	656,425	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares of common stock represent shares of restricted stock that shall vest on October 7, 2026 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service.

Remarks:

Exhibit 24.1: Power of Attorney

	/s/ Michael Lawless, Attorney-in-Fact for Gary S. Roubin	10/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did InspireMD (NSPR) report on the Form 4 filed 10/08/2025?

The Form 4 reports that director Gary S. Roubin was granted 48,000 restricted shares on 10/07/2025 that vest on 10/07/2026.

How many shares will Gary S. Roubin own after the reported transaction?

Following the reported grant, the director's beneficial ownership is 656,425 shares.

What is the price paid for the restricted shares reported on the Form 4?

The restricted shares were issued at a price of $0 as disclosed in the Form 4.

When do the 48,000 restricted shares vest?

The shares vest on the One Year Grant Anniversary Date: 10/07/2026, subject to continued service.

Was the Form 4 filed jointly or by one reporting person?

The Form 4 was filed by one reporting person (the director) as indicated on the form.